NCT00648024View on ClinicalTrials.gov

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Healthy
Interventions
DRUG

Anagrelide Hydrochloride Capsules 1 mg

1mg, single dose fasting

DRUG

Agrylin® Capsules 1 mg

1mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648024 - Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg | Biotech Hunter | Biotech Hunter